Annual Total Liabilities
$3.26 M
-$2.40 M-42.41%
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings annual total liabilities is currently $3.26 million, with the most recent change of -$2.40 million (-42.41%) on 30 September 2024. During the last 3 years, it has fallen by -$3.48 million (-51.64%). SONN annual total liabilities is now -61.08% below its all-time high of $8.37 million, reached on 30 September 2022.SONN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$3.26 M
+$78.10 K+2.46%
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings quarterly total liabilities is currently $3.26 million, with the most recent change of +$78.10 thousand (+2.46%) on 30 September 2024. Over the past year, it has increased by +$491.50 thousand (+17.77%). SONN quarterly total liabilities is now -90.50% below its all-time high of $34.27 million, reached on 31 March 2020.SONN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SONN Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -42.4% | +17.8% |
| 3 y3 years | -51.6% | -25.1% |
| 5 y5 years | +12.9% | - |
SONN Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -61.1% | at low | -61.6% | +17.8% |
| 5 y | 5 years | -61.1% | +12.9% | -90.5% | +17.8% |
| alltime | all time | -61.1% | +12.9% | -90.5% | +17.8% |
Sonnet BioTherapeutics Holdings Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | $3.26 M(-42.4%) | $3.26 M(+2.5%) |
| June 2024 | - | $3.18 M(+11.3%) |
| Mar 2024 | - | $2.86 M(+3.2%) |
| Dec 2023 | - | $2.77 M(-51.1%) |
| Sept 2023 | $5.66 M(-32.4%) | $5.66 M(-14.5%) |
| June 2023 | - | $6.62 M(-16.7%) |
| Mar 2023 | - | $7.94 M(-6.3%) |
| Dec 2022 | - | $8.48 M(+1.3%) |
| Sept 2022 | $8.37 M | $8.37 M(+24.4%) |
| June 2022 | - | $6.73 M(+3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $6.51 M(+49.7%) |
| Dec 2021 | - | $4.35 M(-35.4%) |
| Sept 2021 | $6.73 M(+35.4%) | $6.73 M(+16.0%) |
| June 2021 | - | $5.81 M(+3.6%) |
| Mar 2021 | - | $5.60 M(+1.5%) |
| Dec 2020 | - | $5.52 M(+11.0%) |
| Sept 2020 | $4.97 M(+72.4%) | $4.97 M(+42.1%) |
| June 2020 | - | $3.50 M(-89.8%) |
| Mar 2020 | - | $34.27 M |
| Sept 2019 | $2.89 M | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual total liabilities?
- What is the all time high annual total liabilities for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual total liabilities year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly total liabilities?
- What is the all time high quarterly total liabilities for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly total liabilities year-on-year change?
What is Sonnet BioTherapeutics Holdings annual total liabilities?
The current annual total liabilities of SONN is $3.26 M
What is the all time high annual total liabilities for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual total liabilities is $8.37 M
What is Sonnet BioTherapeutics Holdings annual total liabilities year-on-year change?
Over the past year, SONN annual total liabilities has changed by -$2.40 M (-42.41%)
What is Sonnet BioTherapeutics Holdings quarterly total liabilities?
The current quarterly total liabilities of SONN is $3.26 M
What is the all time high quarterly total liabilities for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly total liabilities is $34.27 M
What is Sonnet BioTherapeutics Holdings quarterly total liabilities year-on-year change?
Over the past year, SONN quarterly total liabilities has changed by +$491.50 K (+17.77%)